Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/10/2011 | WO2011139369A1 Method of functionalizing human red blood cells with antibody |
11/10/2011 | WO2011138557A2 Use of an anti-cd71 antibody for preparing a medicament |
11/10/2011 | WO2011138462A1 Diagnostic method for the detection of cells ex vivo |
11/10/2011 | WO2011138392A1 Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies |
11/10/2011 | WO2011138391A1 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies |
11/10/2011 | WO2011138354A1 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
11/10/2011 | WO2011138279A1 Novel antibody to a carbonic anhydrase |
11/10/2011 | WO2011137687A1 Antibody against carcinoembryonic antigen and uses thereof |
11/10/2011 | WO2011137571A1 Human-derived neutralizing antibody rvfab5 against rabies virus glycoprotein |
11/10/2011 | WO2011137570A1 Human-derived neutralizing antibody rvfab8 against rabies virus glycoprotein |
11/10/2011 | WO2011137569A1 Humanized neutralizing antibody rvfab3 against rabies virus glycoprotein |
11/10/2011 | WO2011120013A9 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
11/10/2011 | WO2011090720A3 Purification of proteins |
11/10/2011 | WO2011050168A3 Rsv immunogens, antibodies and compositions thereof |
11/10/2011 | WO2011035205A3 Antibodies against candida, collections thereof and methods of use |
11/10/2011 | WO2004058052A8 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
11/10/2011 | US20110277177 Soybean Genes for Resistance to Aphis Glycines |
11/10/2011 | US20110277048 Transgenic Aves Producing Human Polyclonal Antibodies |
11/10/2011 | US20110277047 Genetically Modified Non-Human Mammals and Cells |
11/10/2011 | US20110277046 Hydrolases, nucleic acids encoding them and methods for making and using them |
11/10/2011 | US20110277043 Desaturases and Process for the Production of Polyunsaturated Fatty Acids in Transgenic Organisms |
11/10/2011 | US20110275791 A B Cell Depleting Agent for the Treatment of Atherosclerosis |
11/10/2011 | US20110275790 Antibodies Against Human IL-22 and Uses Therefor |
11/10/2011 | US20110275789 Methods and Kits for Detection of Thromboxane A2 Metabolites |
11/10/2011 | US20110275787 Cross-species-specific single domain bispecific single chain antibody |
11/10/2011 | US20110275526 Glycosyl transferase from chinese hamster and related methods |
11/10/2011 | US20110275149 Hybridoma producing antibodies to lawsonia intracellularis |
11/10/2011 | US20110275148 Hybridoma producing antibodies to lawsonia intracellularis |
11/10/2011 | US20110275147 Hybridoma producing antibodies to lawsonia intracellularis |
11/10/2011 | US20110275107 Long wavelength engineered fluorescent proteins |
11/10/2011 | US20110275099 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
11/10/2011 | US20110275086 Negative correlation between irp-2 and transferrin receptor expression as a diagnostic of alzheimer's disease |
11/10/2011 | US20110275059 Diagnostic Transcript and Splice Patterns of HR-HPV in Different Cervical Lesions |
11/10/2011 | US20110274702 Neutralizing anti-influenza a virus antibodies and uses thereof |
11/10/2011 | US20110274700 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF |
11/10/2011 | US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto |
11/10/2011 | US20110274696 Antibodies to ccr2 |
11/10/2011 | US20110274694 ERK1/2 Posphorylation Site Specific Antibody |
11/10/2011 | US20110274693 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
11/10/2011 | US20110274692 Screening Methods |
11/10/2011 | US20110274691 Ferroportin antibodies and methods of use |
11/10/2011 | US20110274690 Compositions and methods for the diagnosis and treatment of tumor |
11/10/2011 | US20110274688 Prevention of tumors with monoclonal antibodies against neu |
11/10/2011 | US20110274686 Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan |
11/10/2011 | US20110274685 Antibodies that bind human cd27 and uses thereof |
11/10/2011 | US20110274684 Cytotoxic antibodies directed against antibodies inhibiting factor viii |
11/10/2011 | US20110274683 Antibodies That Bind CSF1R |
11/10/2011 | US20110274675 Therapeutically Useful Molecules |
11/10/2011 | US20110274618 Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof |
11/10/2011 | US20110274617 Antibody-Targeted Carrier For Contrast Agents |
11/10/2011 | CA2805267A1 Detection and treatment of fibrosis |
11/10/2011 | CA2794864A1 Compositions and methods useful for reducing the viscosity of protein-containing formulations |
11/10/2011 | CA2793544A1 Compositions and methods for the diagnosis and treatment of tumor |
11/09/2011 | EP2385118A1 In vitro peptide expression library |
11/09/2011 | EP2385116A1 Nucleic acid derived from hepatitis c virus, and expression vector, transformed cell and hepatitis c virus particles each prepared by using same |
11/09/2011 | EP2385114A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody |
11/09/2011 | EP2385109A2 A group of esterases for the enantioselective production of fine and speciality chemicals |
11/09/2011 | EP2385071A1 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1 |
11/09/2011 | EP2385070A1 Il-18 binding proteins |
11/09/2011 | EP2385069A2 Neonatal Fc rReceptor (FcRn)- binding polypeptide variants, dimeric Fc binding proteins and methods related thereto |
11/09/2011 | EP2385068A1 Polyclonal antiserum for use in immunotherapy |
11/09/2011 | EP2385067A1 Artificial antibody polypeptides |
11/09/2011 | EP2384767A1 Antibodies that bind OV064 and methods of use therefor |
11/09/2011 | EP2384766A1 Novel antibody to a carbonic anhydrase |
11/09/2011 | EP2384441A1 Isolated peptides of rabbit factor vii |
11/09/2011 | EP2384339A2 Treatment of autoimmune disease by modulating annexin-1 (lipocortin 1) |
11/09/2011 | EP2183599B1 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest |
11/09/2011 | EP1660654B1 Expression vector |
11/09/2011 | EP1541680B1 Cytotoxic antibody against a c-terminal peptide of gpc3 |
11/09/2011 | EP1539817B1 Immunoassays for specific determination of scca isoforms |
11/09/2011 | EP1513554B9 Cd16a binding proteins and use for the treatment of immune disorders |
11/09/2011 | EP1420631B1 Plant-derived resistance gene |
11/09/2011 | EP1328624B1 B7-like molecules and uses thereof |
11/09/2011 | EP1313769B2 Antibodies to human il-1 beta |
11/09/2011 | EP1062337B1 Human n-type calcium channel isoform and uses thereof |
11/09/2011 | EP1001815B1 Vectors derived from antibodies for transferring substances into cells |
11/09/2011 | CN1555414B Plant-derived resistance gene |
11/09/2011 | CN102239251A Bovine viral diarrhea virus with a modified erns protein |
11/09/2011 | CN102239182A Muc1* antibodies |
11/09/2011 | CN102239181A Methods for identifying immunobinders of cell-surface antigens |
11/09/2011 | CN102239180A Antibodies to ccr2 |
11/09/2011 | CN102239179A Integrin peptide, anti-cd 18 ssa antibody for treatment of endotoxin-mediated pro-inflammatory responses and the use |
11/09/2011 | CN102239178A Inhibition of plgf to treat philadelphia chromosome positive leukemia |
11/09/2011 | CN102238963A Fully human influenza m2 specific antibodies |
11/09/2011 | CN102238962A Anti-ferroportin 1 monoclonal antibodies and uses thereof |
11/09/2011 | CN102236017A Indirect ELISA kit for detecting African swine fever virus antibody and application thereof |
11/09/2011 | CN102234641A Method for rapidly acquiring variable region gene sequence of specific human antibody |
11/09/2011 | CN102234633A Human ubiquitin-conjugating enzyme UbcH10 monoclonal antibody hybrid tumor DY02 and monoclonal antibody |
11/09/2011 | CN102234632A Hybrid tumor DY01 of monoclonal antibody of human ubiquitin-conjugating enzyme UbcH10, and monoclonal antibody |
11/09/2011 | CN102234631A Human ubiquitin-conjugating enzyme UbcH10 monoclonal antibody hybrid tumor DY03 and monoclonal antibody |
11/09/2011 | CN102234334A Immunoglobulin chimeric monomer - dimer heterozygote |
11/09/2011 | CN102234333A Establishment of preparation and rapid detection method for polyclonal antiserum of DDT (dichlorodiphenyltrichloroethane) metabolite DDA (2,2-bis(4-chlorophenyl)acetic acid) |
11/09/2011 | CN101987872B Monoclonal antibody TBEF3 of tubercle bacillus-resistant ESAT-6 and application |
11/09/2011 | CN101985474B Monoclonal antibody TBCA6 resistant to mycobacterium tuberculosis CFP-10 and application |
11/09/2011 | CN101985473B Monoclonal antibody TBEF3 of tubercle bacillus-resistant ESAT-6 and application thereof |
11/09/2011 | CN101704891B Antibody for epidermal growth factor receptor, encoding gene thereof and application thereof |
11/09/2011 | CN101691403B Envelope protein VP28 idiotype monoclonal antibody against shrimp white spot syndrome virus (WSSV) and preparation method thereof |
11/09/2011 | CN101434655B Preparation of egg yolk antibody against citrinin |
11/09/2011 | CN101280016B Cocaine-and amphetamine-regulated transcript peptides single-chain antibody and application thereof |
11/08/2011 | US8053564 Biological effectors; S-[3-({2-(3-{[3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl]amino}propoxy)-1,1-bis[3-{[3-(2,5-dioxo-2,5-dihydro-1 H-pyrrol-1-yl)propanoyl]amino}propoxy)methyl]ethyl}amino)-3-oxopropyl]ethanethioate |